1. Home
  2. LFVN

LFVN

Lifevantage Corporation (Delaware)

as 04-18-2025 1:38pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Founded: N/A Country:
United States
United States
Employees: N/A City: LEHI
Market Cap: N/A IPO Year: N/A
Target Price: $30.50 AVG Volume (30 days): 168.7K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
1.19%
Dividend Payout Frequency: Quarterly
EPS: 0.56 EPS Growth: 139.37
52 Week Low/High: $5.22 - $27.38 Next Earning Date: 05-01-2025
Revenue: $212,152,000 Revenue Growth: 0.57%
Revenue Growth (this year): 22.17% Revenue Growth (next year): 8.73%

LFVN Daily Stock ML Predictions

Stock Insider Trading Activity of Lifevantage Corporation (Delaware) (LFVN)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
BEINDORFF MICHAEL A LFVN Director Feb 10 '25 Sell $19.54 5,850 $114,309.00 44,168
Latham Cynthia LFVN Director Feb 10 '25 Sell $20.02 4,450 $89,089.00 51,348
Greer Raymond B LFVN Director Feb 10 '25 Sell $20.15 8,000 $161,221.60 99,288

Share on Social Networks: